Is Biophytis SA halal to invest in?

According to Musaffa's Shariah screening methodology, Biophytis SA (ALBPS.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Biophytis SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biophytis SA using these criteria to determine its compliance status.

Can Muslims buy shares of Biophytis SA?

Muslim investors may consider investing in Biophytis SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Biophytis SA classified as NOT HALAL?

Musaffa determines the Shariah status of Biophytis SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Biophytis SA updated?

The Shariah compliance status of Biophytis SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Biophytis SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Biophytis SA?

You can check the latest Shariah compliance status of Biophytis SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Biophytis SA ALBPS.PA

€0.02

Last Updated: May 15, 12:00 AM·XPAR

ALBPS.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 26, 2025

Report Source: 2024 2nd Quarter Report

Analyst's Ratings for Biophytis SA (ALBPS.PA)

Based on 9 analysts giving stock ratings to Biophytis SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Biophytis SA. Stock Analysis ALBPS.PA

France Health Care Nano Cap Report: Q2, 2024

Biophytis SA operates as a clinical-stage biotechnology company. The company employs 18 full-time employees The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

Key Statistics of Biophytis SA (ALBPS.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.02€0.02

Today's Open

€0.02

Volume

2081.00

P/E Ratio (TTM)

52 Week Range

€0.02€0.22

Market Cap

1.75M

Avg. Volume

4.17M

Dividend Yield

Financial Metrics & Statements of Biophytis SA (ALBPS.PA)

FAQ's for Biophytis SA (ALBPS.PA)

According to Musaffa’s Shariah screening methodology, Biophytis SA (ALBPS.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.